Анжелик: клиническая эффективность и влияние на некоторые лабораторные показатели

1. Вихляева Е.М. Руководство по эндокринной гинекологии. М., 2000; 179–80.
2. Maheux R, Guy J, Dumont M, Masse B. Correlation Between Skin Thickness and Bone Mass in Women. Menopause 1996; 3 (4): 197–200.
3. Sator PG, Schmidt JB, Rabe T, Zouboulis CC. Skin aging and sex hormones in women – clinical perspectives for intervention by hormone replacement therapy. Exp Dermatol 2004; 13 (Suppl. 4): 36–40.
4. Miodrag A, Castleden CM, Vallance TR. Sex hormones and the female urinary tract. Drugs 1988; 36: 491–504.
5. Okazaki M,Yoshimura K, Uchida G, HariiK. Correlation between age and the secretions of melanocyte-stimulating cytokines in cultured keratinocytes and fibroblasts. Br J Dermatol 2005; 153 (Suppl. 12): 23–9.
6. Thornton MJ. The biological actions of estrogens on skin. Exp Dermatol 2002; 11 (6): 487–502.
7. Meldrum DR, Davidson RJ, Tatarum JV, Judd HC. Changes in circulating steroid with aging in postmenopausal women. Obstet Gynecol 1981; 57 (5): 624–8.
8. Brincat MP. Maturitas 2000; 35: 107–17.
9. Asheroft GS, Dodsworth J, vanBoxtel E et al. Nat Med 1997; 3 (11): 1209.
10. Grosman N, Hvidberg E, Schou J. The effect of oestrogenic treatment on the acid mucopolysaccharide pattern in skin of mice. Acta Pharmacol Toxicol (Copenh) 1971; 30 (5): 458–64.
11. Brincat M, Kabalan S, Studd JW et al. A study of the decrease of skin collagen content, skin thickness, and bone mass in the postmenopausal woman. Obstet Gynecol 1987; 70 (6): 840–5.
12. Anttinen H, Orava S, Ruhanen L, Kivirikko KI. Assay of protocollagen lysyl hydroxylase activity in the skin of human subjects and changes in the activity with age. Clin Chim Acta 1973; 47 (2): 289–94.
13. Brincat M, Moniz CF, Kabalan S et al. Decline in skin collagen content and metacarpal index after the menopause and its revention with sex hormone replacement. Br J Obstet Gynaecol 1987; 94 (2): 126–9.
14. Metka M, Enzelsberger H, Knogler W et al. Eye manifestations as climacteric symptom. Geburtshilfe-Frauenheilkd 1991; 51: 143–5.
15. Boucek RJ, Noble NL, Woessner JrJF. Properties of fibroblasts. In: Page, IH (Ed.), Connective tissue thrombosis and atherosclerosis. Academic Press, New York, p. 193–211.
16. Danforth DN, Veis A, Breen M et al. The effect of pregnancy and labor on the human cervix:changes in collagen, glycoproteins, and glycosaminoglycans. Am J Obstet Gynecol 1974; 120 (5): 641–51.
17. Hartmann BW, Huber JC. The mythology of hormone replacement therapy (see comments). Br J Obstet Gynaecol 1997; 104 (22): 163–8.
18. Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 2001; 58: 529–34.
19. Hermann PG, Schneider J. Hormone Replacem Ther Quality Life: 2002; 150.
20. Phillips TJ, Demircay Z, Sahu M. Hormonal effects on skin aging. Clin Geriatr Med 2001; 17 (4): 661–72.
21. Lomax P, Schonbaum E. Postmenopausal hot flushes and their management. Pharmacol Ther 1993; 57 (2–3): 347–58.
22. Fletcher AE, Bulpitt CJ. Measurement of quality of life in clinical trials therapy. Cardiology 1987; 75 (Suppl. 1): 41–52.

Ю.Э.Доброхотова, И.М.Корсунская, Е.М.Зеленская, Е.Г.Бигвава, Т.В.Кузьмина

Кафедра акушерства и гинекологии Московского факультета с курсом ФУВ Российского государственного 
медицинского университета, Московская медицинская академия им. И.М.Сеченова